Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Winter Games
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

FDA refuses review of mRNA flu vaccine

Digest more
Top News
Overview
Scientific American · 10h
FDA won’t consider a new mRNA vaccine for flu, despite the technology’s life-saving promise
The U.S. Food and Drug Administration is refusing to consider a new mRNA flu vaccine made by Moderna, the company revealed in a statement on Tuesday.

Continue reading

 · 3h
Moderna says FDA refuses its application for new mRNA flu vaccine
GBH · 5h
Local health experts question FDA's refusal to review Moderna's application for a new mRNA flu vaccine
 · 16h
F.D.A. Refuses to Review Moderna Flu Vaccine
The vaccine maker Moderna said on Tuesday that the Food and Drug Administration had notified the company that the agency would not review its mRNA flu vaccine, the latest sign of federal health policy...

Continue reading

 · 1d
FDA refuses to review Moderna’s application for mRNA flu vaccine, company says
 · 1d
FDA Refuses to Consider Approving Use of Moderna’s New Flu Vaccine
Yahoo
6mon

mRNA tech could help fight cancer, but cuts threaten progress, experts say

If you think last week's decision by the federal government to halt $500 million in funding for vaccine development projects that use mRNA technology will only affect COVID vaccines, think again. These types of vaccines use messenger RNA, or mRNA, to ...
BioSpace
12d

Sanofi Moves Away From mRNA Flu Vaccine as CEO Projects Confidence

Despite Sanofi CEO Paul Hudson’s confidence in vaccines, the French pharma has cut at least one mRNA flu shot program.
  • Privacy
  • Terms